Institutional investors purchased a net $2.0 million shares of AEGR during the quarter ended March 2016, and now own 103.80% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SARISSA CAPITAL MANAGEMENT LP Bought 69.0 Thousand shares of Aegerion Pharmaceuticals ...